Company

Sojournix Inc.

Sojournix Inc. is a Waltham biotechnology company developing therapeutics for neurological disorders.

About

Founded in 2016 and headquartered in Waltham, US, the company develops therapeutics for neurological conditions, including depression and anxiety. Its Series C round in January 2019 raised USD 44 mn from investors including Boxer Capital and Frazier Healthcare Partners. CEO Daniel Grau leads the company, which has completed four deals.

4Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in